US Navy sees the light

Article

The US Navy is proceeding with a programme allowing LASIK with IntraLase flap creation in naval aviators.

The US Navy is proceeding with a programme allowing LASIK with IntraLase flap creation in naval aviators. Until this point, PRK has been the preferred method of choice for refractive surgical correction.

Steven Schallhorn, MD of the Naval Medical Center in San Diego, US, speaking at the Hawaiian Eye 2007, discussed how the military has been reluctant to allow LASIK because contrast sensitivity took longer to be recovered postoperatively than after PRK. However, it was noted that there is a slow visual recovery period, of around three months, after PRK, whereas LASIK offers much faster recovery times.

Dr Schallhorn spoke of the technological advancements in LASIK. One large series study comparing conventional to wavefront-guided LASIK found that the addition of wavefront technology results in fewer higher-order corneal aberrations and therefore better postoperative vision. Another study found better quality of vision and faster visual recovery using the IntraLase femtosecond laser for flap creation compared with mechanical microkeratomes.

As a result of theses studies, the US Navy are prepared to begin a cautious programme allowing LASIK with IntraLase on naval aviators.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.